Synergistic role of exercise and liraglutide in modulating GLP-1R binding and metabolic outcomes: a combined computational and experimental study.
3 Biotech · 2026
Last updated 2026-08-28| Journal | 3 Biotech, 2026 |
|---|---|
| Citations | 0 |
| Molecules | liraglutide |
Abstract
Exercise-induced ionic changes can modulate the interaction between liraglutide and the glucagon-like peptide-1 receptor (GLP-1R). To investigate this, molecular dynamics simulations and in vivo experiments using streptozotocin-induced diabetic rats were performed. Under exercise-mimicking ionic conditions (NaCl 129 mM, KCl 8.5 mM), the simulations revealed enhanced stability of the liraglutide-GLP-1R complex, evidenced by reduced interatomic distances, a lower radius of gyration, increased ligand flexibility (as indicated by RMSF), higher solvent-accessible surface area, and stronger binding energy. Structural analysis using PDBsum identified one salt bridge, two hydrogen bonds, and eighty-nine non-bonded contacts between liraglutide and key receptor residues, confirming a robust and stable interaction. In diabetic rats, the combined treatment with liraglutide and exercise significantly decreased body weight and plasma glucose levels ( < 0.001), improved lipid profiles, and enhanced insulin sensitivity. These effects were accompanied by a significant increase in the expression of mitochondrial regulators PGC-1α and UCP-1 ( < 0.01), indicating enhanced mitochondrial biogenesis and thermogenic capacity.
Verbatim abstract via PubMed 41710474 ↗
Related research
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
- Liraglutide and Renal Outcomes in Type 2 Diabetes.
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
- The Discovery and Development of Liraglutide and Semaglutide.